$APOG

APOGEE ENTERPRISES, INC. Q2 FY2027: Revenue $391.1M, EPS $1.07— 10-Q Summary

Apogee Enterprises reported Q2 FY2027 revenue of $391.1M, up 9.2% YoY, but net income fell 5.3% to $22.38M. EPS was flat at $1.07. Growth was driven by the Kalwall acquisition and pricing strategies, while margins improved due to productivity gains and cost savings.

Original reporting
Published Oct 6, 2026, 8:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
APOGEE ENTERPRISES, INC. Q2 FY2027: Revenue $391.1M, EPS $1.07— 10-Q Summary — source image
Decision brief

The 30-second read

$APOGNeutralMed
01

Why it matters

The earnings numbers are the first public disclosure, offering fresh data for valuation models.

02

Market read

Earnings release provides new quantitative data for a small‑cap industrial stock, with limited broader market impact.

03

What to watch

Potential upside from the recent Kalwall acquisition and Project Fortify cost‑savings not yet reflected in earnings.

Relevance 7/10Novelty 7/10Timing: after‑hours release

Background

APOGEE ENTERPRISES, INC. filed its Q2 FY2027 10‑Q, reporting revenue growth and a flat EPS figure.

Company-level read

Ticker impact

$APOGNeutralHigh confidence
Context

Q2 FY2027 10‑Q shows revenue up 9.2% to $391.1M while EPS is flat at $1.07, marking the first public disclosure of these results.

Expected impact

likely slight pressure as investors digest flat EPS despite revenue increase

Evidence & confidence

The earnings release is new information; modest top‑line growth does not offset unchanged earnings, limiting upside.

Market effects

Provides a data point for the architectural glass and construction materials sector, indicating modest demand growth.

Limited to U.S. investors tracking small‑cap industrial stocks.

Low global relevance; impact confined to niche market participants.

Counterpoint

Flat EPS could be a buying opportunity if the market overreacts to the modest revenue gain.

Key entities

  • APOGEE ENTERPRISES, INC.

    U.S. architectural glass and construction materials manufacturer.

Related articles

$LWHighAI 8/10

US Stock Movers: Lamb Weston, Option Care, Apogee Rally

Lamb Weston (LW) shares rose 11.85% after reporting Q1 sales of $1.67B and raising 2027 EBITDA guidance. Option Care (OPCH) jumped 32.8% on a $5.8B take-private deal. Apogee (APOG) gained 18.7% on strong Q2 earnings and raised FY2027 outlook. Constellation (CEG) surged 14.79% after a Google nuclear deal. RPM (RPM) rose 2.5% on record Q1 results.

$APOGHighAI 8/10

Apogee (APOG) Q2 2027 Earnings Call Transcript

Apogee (APOG) reported Q2 2027 earnings with net sales up 9.2% to $391.1M, driven by acquisitions and pricing. Adjusted EBITDA margin rose to 12.7%, and EPS increased 19% to $1.17. The company highlighted progress in metals, services, and glass segments, with services delivering 10 consecutive quarters of growth. Acquisitions of Kalwall and GrowGlass are expected to enhance capabilities and profitability. Management expressed confidence in long-term growth and shareholder value creation.

$APOGMedAI 8/10

Apogee Enterprises Inc (APOG) (Q2 2027) Earnings Call Highlights: Raised Guidance

Apogee Enterprises (APOG) reported Q2 2027 revenue of $391M, up 9% YoY, and adjusted EPS of $1.17, up 19%. The company raised its fiscal 2027 outlook due to strong first-half performance. Segment performance varied, with Services growing for the 10th consecutive quarter, while Glass and Performance Surfaces faced challenges. Acquisitions of Kalwall and Groglass are progressing well. Leverage ratio is 1.7 times, slightly above target. The company repurchased $6.4M of stock in Q2.

$APOGHighAI 8/10

Apogee raises fiscal 2027 guidance after second-quarter sales rise

Apogee Enterprises (APOG) reported a 9.2% sales increase to $391.1M in Q2, raising its fiscal 2027 adjusted EPS guidance to $3.00-$3.40 and net sales outlook to $1.46B-$1.50B. Operating income rose 24.5% to $33.5M, while net earnings fell 5.4% to $22.4M. Growth was driven by acquisitions, pricing, and product mix, though offset by lower volume and higher costs.

$APOGMed

Apogee Enterprises Q2 Earnings Call Highlights

Apogee Enterprises reported Q2 sales growth in all segments, with Architectural Metals up 1.8%, Services up 8%, Glass up 21%, and Performance Surfaces up 14%. Adjusted EBITDA margins varied, with Glass improving sequentially. The company expects Kalwall and Groglass acquisitions to boost revenue but have a modest EPS impact in 2027. Apogee repurchased $6.4M in stock and paid $5.5M in dividends, maintaining a leverage ratio of 1.7x.

$CEGHighAI 8/10

Market movers: Constellation Energy, Marvell, Lamb Weston, Option Care

Diodes (DIOD) received a buy rating and $135 target from BofA, expecting 58% annual EPS growth. Apogee (APOG) raised fiscal 2027 guidance after Q2 sales rose 9.2%. Marvell (MRVL) shares rose 6.5% on $70B-$90B 2031 revenue forecast. Lamb Weston (LW) increased 2027 targets despite net income drop. SAP (SAP) to acquire TechWolf; Mckesson (MCK) & CD&R to buy Option Care Health (OPCH) for $5.8B. Constellation Energy (CEG) in 20-year PPA with Alphabet (GOOG).